Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis

scientific article published on 15 March 2016

Disease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1759720X16635887
P932PMC publication ID4794953
P698PubMed publication ID27047572

P2093author name stringAshit Syngle
Inderjeet Verma
Pawan Krishan
Vijaita Syngle
P2860cites workCardiovascular comorbidity in rheumatic diseases: a focus on heart failureQ26823443
Reflex principles of immunological homeostasisQ27026999
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxinQ29615449
Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatmentQ33165286
The relationship between heart rate variability and inflammatory markers in cardiovascular diseasesQ33372271
Cardiovascular involvement in autoimmune diseasesQ34081242
Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritisQ34796766
Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammationQ35504243
Abnormal autonomic cardiovascular control in ankylosing spondylitisQ35548753
RR interval variability is inversely related to inflammatory markers: the CARDIA studyQ35844062
Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammationQ36403437
Autonomic dysfunction in autoimmune rheumatic diseaseQ37459236
Autonomic neuropathy: its diagnosis and prognosisQ39748132
Sulphasalazine: mechanism of action in rheumatoid arthritis.Q40931433
Effects of antirheumatic agents on cytokinesQ41133430
Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failureQ44357069
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in ratsQ46795301
Autonomic dysfunction in psoriatic arthritisQ46978109
Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons.Q50260435
Reflex control of inflammation by sympathetic nerves, not the vagus.Q50665775
Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk.Q51569066
The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study.Q51703227
Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study.Q51717064
The Vagus Nerve and Nicotinic Receptors Modulate Experimental Pancreatitis Severity in MiceQ60692880
Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structuresQ73966791
Classification criteria for psoriatic arthritis: development of new criteria from a large international studyQ80001900
Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseasesQ80153362
Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosusQ82266347
P433issue2
P921main subjectautonomic neuropathyQ18554095
P304page(s)42-48
P577publication date2016-03-15
P1433published inTherapeutic advances in musculoskeletal diseaseQ26841913
P1476titleDisease-modifying antirheumatic drugs improve cardiovascular autonomic neuropathy in psoriatic arthritis
P478volume8

Search more.